Augustine Therapeutics NV
Augustine Therapeutics (NV) is a company in Leuven, active in research and experimental development on natural sciences and engineering, founded in 2019, with 11 employees (full-time equivalents). Financial year 2025: gross margin -€1.66m, profit -€14.79m, equity €28.98m.
1 warning: three consecutive years of losses1 point of attentionShowHide
- Explained →
Three consecutive years of losses. Loss in 2023, 2024, 2025 (€ -14,788,759 in 2025).
Source: NBB, annual accounts 2023 to 2025
Figures for Augustine Therapeutics, 2025NBB · abridged format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about Augustine Therapeutics
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Annual accounts 2024 filed
- Annual accounts 2023 filed
- Incorporated as naamloze vennootschap
Activities NACE-BEL 2025
Establishments 1
- Gaston Geenslaan 3, 3001 Leuven · since 13/03/20192.289.870.882
AuditProSanctions and politically exposed persons
Is a director on a sanctions list, or do they share the name of a politically exposed person? You can see it with Nummo Pro. Start your free trial
Publications in the Belgian Official Gazette 16 publications
- 17/06/2025BoardDiversen, ontslagen, benoemingenDeed (pdf)
- 21/05/2025BoardOntslagen, benoemingenDeed (pdf)
- 12/02/2025Incorporation and articlesBoardCapitalStatuten (vertaling, coördinatie, overige wijzigingen, ), kapitaal, aandelen, ontslagen, benoemingenDeed (pdf)
All 16 publications → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more